Allo, Erlyn G.
HRN: 12-42-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
CEFTAZIDIME 1GM (VIAL)
04/19/2023
04/26/2023
IV
1gm
Q6H
CAP MR; T/C PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes